The reason is that although this is trading in pennys its not really a penny stock... and the RS will most assuredly get this over $5 most likely $8 or more... and if as I and many others believe this will have a positive results for the Phase 3. If that happens and the stock is already due to the $5 to $8 dollar range then its going to fly while they await an almost guaranteed approval by the FDA...
If you follow Bio Tech stock like I do and you have seen what happens to them when there are positive results... it will go from $8 to $70 and there is plenty of verifiable history to back it up... google drug stocks that have had giant gains based on drug approval... it will go there because institutional investors will buy this up and force it up... the projections for this drug are in the billions of dollars over a 8 year span and they have exclusive rights until 2035 ... so its not a penny stock having a reverse split its a 0-16 Detriot Lions team all of a sudden becoming the 70's Dolphins team that went undefeated... thats the kind of turn around this is going to have... So the RS is not a concern... on the outside chance that the results are not positive then the company goes broke in 16 months. RS or not.
News 
Market Data 
Discover 
AI
